WEC
53
5
WMT
56
-4
ECL
55
-2
HST
39
-3
OMC
50
-16
GME
66
-5
SHW
62
-6
GILD
47
-8
CHD
54
4
MS
77
-2
PYPL
52
-2
UPS
48
2
CINF
53
3
ILMN
32
-9
KSS
39
-7
NWS
75
-4
INTC
41
4
BEN
50
9
VMC
53
-4
UAL
83
-2
WEC
53
5
WMT
56
-4
ECL
55
-2
HST
39
-3
OMC
50
-16
GME
66
-5
SHW
62
-6
GILD
47
-8
CHD
54
4
MS
77
-2
PYPL
52
-2
UPS
48
2
CINF
53
3
ILMN
32
-9
KSS
39
-7
NWS
75
-4
INTC
41
4
BEN
50
9
VMC
53
-4
UAL
83
-2
Financhill
Back

Steven Madden Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
42

SHOO
Steven Madden

Last Price:
43.25
Seasonality Move:
7.71%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
42
Steven Madden (SHOO) is a Sell

Is Steven Madden a Buy, Sell or Hold?

  • The current Steven Madden [SHOO] share price is $43.23. The Score for SHOO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • SHOO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SHOO Stock Price Chart

What is Steven Madden's stock price today?

  • The Steven Madden share price today is $43.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SHOO is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

SHOO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 35.28 Sell
Chaikin Money Flow: -605757 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.19 - 47.13) Sell
Bollinger Bands (100): (42.88 - 46.98) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

SHOO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.46 Sell
20-day SMA: 45.02 Sell
50-day SMA: 46.32 Sell
200-day SMA: 43.45 Sell
8-day EMA: 44.33 Sell
20-day EMA: 45.1 Sell
50-day EMA: 45.56 Sell
200-day EMA: 43.32 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Steven Madden Earnings Growth & SHOO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.26 per share, and an increase next year of $0.35 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Steven Madden Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):